The controversial taNRP protocol shortens ischemic time for donations after circulatory death and improves outcomes.

Yet the disparities by sex, race/ethnicity, and location pale in comparison to a striking overall lack of adoption.

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.